Cyclacel Pharmaceuticals Inc (CYCC)
0.39
-0.06
(-14.29%)
USD |
NASDAQ |
Nov 14, 16:00
0.39
0.00 (0.00%)
After-Hours: 16:51
Cyclacel Pharmaceuticals Shareholders Equity (Quarterly): 0.999M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 0.999M |
March 31, 2024 | -2.206M |
December 31, 2023 | 0.607M |
September 30, 2023 | 4.297M |
June 30, 2023 | 9.63M |
March 31, 2023 | 14.64M |
December 31, 2022 | 20.43M |
September 30, 2022 | 26.56M |
June 30, 2022 | 30.21M |
March 31, 2022 | 33.41M |
December 31, 2021 | 37.69M |
September 30, 2021 | 41.36M |
June 30, 2021 | 43.22M |
March 31, 2021 | 48.05M |
December 31, 2020 | 33.26M |
September 30, 2020 | 24.44M |
June 30, 2020 | 26.58M |
March 31, 2020 | 10.39M |
December 31, 2019 | 11.70M |
September 30, 2019 | 13.85M |
June 30, 2019 | 15.73M |
March 31, 2019 | 17.56M |
December 31, 2018 | 15.27M |
September 30, 2018 | 16.60M |
June 30, 2018 | 18.62M |
Date | Value |
---|---|
March 31, 2018 | 20.40M |
December 31, 2017 | 21.77M |
September 30, 2017 | 23.46M |
June 30, 2017 | 11.64M |
March 31, 2017 | 12.82M |
December 31, 2016 | 14.27M |
September 30, 2016 | 16.94M |
June 30, 2016 | 13.16M |
March 31, 2016 | 15.90M |
December 31, 2015 | 18.84M |
September 30, 2015 | 21.60M |
June 30, 2015 | 24.10M |
March 31, 2015 | 27.03M |
December 31, 2014 | 21.69M |
September 30, 2014 | 24.64M |
June 30, 2014 | 29.59M |
March 31, 2014 | 24.98M |
December 31, 2013 | 28.02M |
September 30, 2013 | 29.01M |
June 30, 2013 | 30.93M |
March 31, 2013 | 10.23M |
December 31, 2012 | 10.02M |
September 30, 2012 | 13.23M |
June 30, 2012 | 15.06M |
March 31, 2012 | 18.54M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-2.206M
Minimum
Mar 2024
48.05M
Maximum
Mar 2021
21.86M
Average
24.44M
Median
Sep 2020
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | -0.617M |
Palatin Technologies Inc | -0.1115M |
iBio Inc | 21.32M |
Theriva Biologics Inc | 27.65M |
Oragenics Inc | 1.326M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 8.19M |
Total Liabilities (Quarterly) | 7.191M |
Current Ratio | 1.072 |